Dubbed by many travel vloggers as “The Hidden Gem of the..
Vaccine manufacturer Pfizer requested the emergency use authorization of its COVID-19 vaccine for children five to 11 years old, the Philippine Food and Drug Administration (FDA) announced.
FDA Chief Eric Domingo said Pfizer submitted their application on December 8 and will likely be approved by the end of the year. The application has been sent to local vaccine experts for evaluation.
Domingo said, once approved, the vaccine will be administered in lower doses for kids.
“In fact, lower dose ang ginagamit sa mga bata dahil syempre mas maliit itong five to 11… ‘Yung kanilang safety data and monitoring right now is good,” the FDA chief said.
Currently, Pfizer is being used for the vaccination of adolescents aged 12 to 17 years old following FDA’s approval in June.
The United States has authorized the use of Pfizer jabs among kids aged 5 to 11. Australia also greenlighted the use of the vaccine among the same age group. Its capital, Canberra, is set to distribute the vaccines to kids by January.
Meanwhile, Sinovac also requested for the emergency use approval of its COVID-19 vaccine among children three to 17 years old. According to Domingo, the Chinese vaccine manufacturer still lacks clinical data trials to prove its safety for pediatric use.